泌尿时讯 发表时间:2025/4/13 22:13:31
编者按:2025年美国癌症研究协会(AACR)年会将于当地时间4月25至30日在美国芝加哥举行,本届年会的主题“融合科学与临床——持续创新带来变革(Unifying Cancer Science and Medicine: A Continuum of Innovation for Impact)”,反映了“实验室—临床—实验室”这一癌症研究过程的重要性。在泌尿肿瘤领域,多项中国研究及新型药物治疗入选,这也体现了中国泌尿肿瘤研究的广度和深度。肿瘤瞭望-泌尿时讯特别整理相关研究题目,以飨读者(如有遗漏和错误,欢迎留言指正)。
摘要号:742 / 27
英文标题:Development and evaluation of a non-invasive qPCR assay for sensitive detection of FGFR2/3 alterations in urine samples as a companion diagnostic for erdafitinib
中文标题:开发并评估一种非侵入性qPCR检测方法,用于高灵敏度检测尿液样本中的FGFR2/3变异,作为厄达替尼的伴随诊断
讲者:Qing Xu. 中国上海
摘要号:LB021 / 21
英文标题:TJ102, A promising bispecific dual-payload ADC targeting CDH6 and folate receptor alpha (FRα) for the treatment of ovarian and kidney cancers
中文标题:TJ102是一种有前景的双特异性双药ADC,靶向CDH6和叶酸受体α(FRα),用于治疗卵巢癌和肾癌
讲者:Shugaku Takeda. 中国上海
摘要号:343 / 10
英文标题:GenSci143, a novel B7-H3×PSMA bispecific and potential best-in-class ADC, for the treatment of metastatic castration-resistant prostate cancer
中文标题:GenSci143,一种新型B7-H3×PSMA双特异性抗体偶联药物,有望成为同类最优ADC药物,用于治疗转移性去势抵抗性前列腺癌
讲者:Fu Li 中国上海
摘要号:353 / 20
英文标题:Preclinical development of MHB048C: A novel anti-PSMA ADC with a potent topoisomerase I inhibitor
中文标题:MHB048C的临床前开发:一种具有强效拓扑异构酶I抑制剂的新型PSMA ADC
讲者:Guoqing Cao 中国杭州
摘要号:576 / 11
英文标题:Discovery of FL801, a B7-H3-targeting nanobody-based radioligand vector, using Clear-XTM linker technology
中文标题:利用Clear-XTM连接技术发现FL801,一种靶向B7-H3的基于纳米抗体的放射性配体载体
讲者:Xiaozhu Wang 中国上海
摘要号:446 / 7
英文标题:Embryonic ectoderm development protein (EED) inhibitor APG-5918 exhibits potent antitumor activity and synergizes with androgen receptor (AR) inhibitor enzalutamide in preclinical prostate cancer (PCa) models
中文标题:胚胎外胚层发育蛋白(EED)抑制剂APG-5918在临床前的前列腺癌(PCa)模型中表现出强大的抗肿瘤活性,并与雄激素受体(AR)抑制剂恩扎卢胺产生协同作用
讲者:Yan Yin 中国苏州
摘要号:396 / 15
英文标题:Discovery of SHR3591, a highly potent and orally bioavailable AR PROTAC for the treatment of prostate cancer
中文标题:SHR3591,一种高效且口服生物可利用的AR PROTAC,用于治疗前列腺癌
讲者:Minqiang Jia 中国上海
摘要号:1015 / 17
英文标题:Real-world evaluation of androgen receptor (AR) ligand-binding domain (LBD) mutations in Chinese patients with metastatic castration-resistant prostate cancer (mCRPC)
中文标题:对中国转移性去势抵抗性前列腺癌(mCRPC)患者雄激素受体(AR)配体结合域(LBD)突变的真实世界评估
讲者:Yufei Chen 中国北京
摘要号:1018 / 20
英文标题:Genetic landscape and functional exploration of kidney cancer predisposition in cross-ancestral populations
中文标题:跨祖先人群肾癌易感性的遗传图谱和功能探索
讲者:Hongji Dai 天津医科大学附属肿瘤医院
摘要号:1924 / 24
英文标题:Urine extracellular vesicles derived CA9 and CIZ1 as non-invasive biomarkers for early diagnosis of clear cell renal cell carcinoma
中文标题:尿液细胞外囊泡衍生的CA9和CIZ1作为透明细胞肾细胞癌早期诊断的非侵入性生物标志物
讲者:Xiyi Wei 南京医科大学第一附属医院
摘要号:1782 / 1
英文标题:Preclinical development of iSAP-0909: A novel self-assembled fluorescent contrast agent targeting XIAP for image-guided surgery in bladder cancer
中文标题:iSAP-0909临床前开发:一种针对XIAP的新型自组装荧光造影剂,用于膀胱癌图像引导手术
讲者:Min Han 中国北京
摘要号:1717 / 18
英文标题:Establishment and characterization of enzalutamide resistant prostate CDX models
中文标题:恩扎卢胺耐药前列腺CDX模型的建立及鉴定
讲者:Wen-Jen Yu. 中国北京
摘要号:1777 / 29
英文标题:OST11098, an orally available and selective Cyp11A1 inhibitor for the treatment of castration-resistant prostate cancer (CRPC) with next-generation hormone agents (NHAs) resistance
中文标题:OST11098是一种口服选择性Cyp11A1抑制剂,用于治疗对下一代激素药物(NHA)有抗药性的去势抵抗性前列腺癌(CRPC)
讲者:Fangrui Wu. 中国苏州
摘要号:1322 / 6
英文标题:The DNA methylation signature of the driver gene GPRASP1 serves as an early indicator of progression in prostate cancer
中文标题:驱动基因GPRASP1的DNA甲基化特征可作为前列腺癌进展的早期指标
讲者:Yi Lu. 南方科技大学
摘要号:3672 / 1
英文标题:High-sensitivity CRISPR-Cas12a detection of prostate-specific antigen based on computationally optimized aptamers
中文标题:基于计算优化配体的前列腺特异性抗原高灵敏度CRISPR-Cas12a检测
讲者:Pei Li. 郑州大学基础医学院
摘要号:CT111 / 6
英文标题:A phase 1, first-in-human study of IB-T101, an OUTLAST™ CAR-T product for the treatment of CD70-positive clear cell renal carcinoma
中文标题:IB-T101(OUTLAST™ CAR-T产品)用于治疗CD70阳性透明细胞肾癌的I期首次人体研究
讲者:中国上海
摘要号:2945 / 19
英文标题:PLB-002 is a novel Claudin 6 antibody-drug conjugate for ovarian cancer and testicular germ cell cancer
中文标题:PLB-002是一种新型Claudin 6抗体偶联药物,用于治疗卵巢癌和睾丸生殖细胞癌
讲者:Haitao Pan 中国苏州
摘要号:2869 / 8
英文标题:DXC014, a novel bispecific ADC targeting B7-H3 and PSMA, demonstrates favorable antitumor efficacy and safety profiles in preclinical evaluations
中文标题:DXC014是一种针对B7-H3和PSMA的新型双特异性ADC,在临床前评估中表现出良好的抗肿瘤疗效和安全性
讲者:Huihui Guo 中国杭州
摘要号:3495 / 3
英文标题:QL535, A novel CD2-costimulating T cell engager targeting PSMA-positive prostate cancer matching CD28 trispecific antibody in cytotoxicity, minimizing cytokine release and T-cell exhaustion
中文标题:QL535,一种新型CD2共刺激T细胞衔接剂,靶向PSMA阳性前列腺癌,与CD28三特异性抗体匹配,具有细胞毒性,可最大限度地减少细胞因子释放和T细胞耗竭
讲者:Xiao Liu 中国济南
摘要号:3439 / 2
英文标题:Study on the mechanism of sesamin inhibiting the malignant metastasis of prostate cancer
中文标题:芝麻素抑制前列腺癌恶性转移的机制研究
讲者:Yen Chen Chen 中国台湾新光吴火狮纪念医院
摘要号:LB273 / 22
英文标题:HSK46575: A best-in-class, long lasting, small molecular CYP11A1 inhibitor for the treatment of castration-resistant prostate cancer (CRPC)
中文标题:HSK46575:同类最佳、长效、小分子CYP11A1抑制剂,用于治疗去势抵抗性前列腺癌(CRPC)
讲者:Lulin Huang 中国成都
摘要号:4224 / 10
英文标题:The pharmacological intervention of protein arginine methyltransferase 1 (PRMT1) leads to metastatic castration-resistant prostate cancer (mCRPC) repression through unique and significant androgen receptor (AR) downregulation and epigenetic modulation
中文标题:蛋白质精氨酸甲基转移酶1(PRMT1)的药物干预通过独特且显著的雄激素受体(AR)下调和表观遗传调节导致转移性去势抵抗性前列腺癌(mCRPC)抑制
讲者:Hui Shi 中国杭州
摘要号:5888 / 13
英文标题:Urinary ctDNA tumor fraction monitoring enhances non-invasive assessment of molecular response in bladder-preserving treatment of muscle-invasive bladder cancer
中文标题:尿液ctDNA肿瘤分数监测可增强对肌层浸润性膀胱癌保留膀胱治疗中分子反应的无创评估
讲者:Haoran Tang 中国上海
摘要号:5889 / 14
英文标题:Combined cfDNA and cfRNA enhanced gene fusion detection and drug resistance mechanism insights in mCRPC through combined cfDNA and cfRNA assays profiling
中文标题:通过联合cfDNA和cfRNA分析,增强mCRPC中的基因融合检测和耐药机制分析
讲者:Haoran Tang 中国上海
摘要号:5905 / 30
英文标题:A non-invasive, methylation-based NGS assay for sensitive detection and monitoring of bladder cancer in urine
中文标题:一种基于甲基化的无创NGS检测方法,用于尿液中膀胱癌的灵敏检测和监测
讲者:Feng Xie 中国上海
摘要号:5123 / 1
英文标题:Up-regulation of KRT14 promotes EMT in basal muscle-invasive bladder cancer through IGF2BP1/FTO dependence on methyladenosine-modified SNAI1
中文标题:KRT14的上调通过依赖甲基腺苷修饰的SNAI1促进基底肌层浸润性膀胱癌的EMT
讲者:Chuanshu Huang. 温州医科大学
摘要号:5247 / 7
英文标题:Comprehensive characterization of pseudocapsules in clear cell renal cell carcinoma reveals unique invasion mechanisms: A multi-omics investigation
中文标题:肾透明细胞癌假包膜的综合表征揭示其独特的侵袭机制:一项多组学研究
讲者:Xiyi Wei, 南京医科大学第一附属医院
摘要号:6611 / 18
英文标题:Genome-wide cfDNA fragmentomics combined with machine learning enhance non-invasive prostate cancer detection
中文标题:全基因组cfDNA片段组学与机器学习相结合,增强非侵入性前列腺癌检测
讲者:Hang Dong. 中国上海
(来源:《肿瘤瞭望-泌尿时讯》编辑部)
声 明
凡署名原创的文章版权属《肿瘤瞭望-泌尿时讯》所有,欢迎分享、转载(开白可后台留言)。本文仅供医疗卫生专业人士了解最新医药资讯参考使用,不代表本平台观点。该等信息不能以任何方式取代专业的医疗指导,也不应被视为诊疗建议,如果该信息被用于资讯以外的目的,本站及作者不承担相关责任。
温馨提示
添加小助手请备注“泌尿”